| http://www.w3.org/ns/prov#value | - The peptides were then purified using reverse-phase high performance liquid chromatography; and peptide identity was confirmed with electrospray mass spectrometry. [0028] As illustrated in this example, provided is a pharmaceutical composition comprised of a solution comprising synthetic peptide in a final concentration of the pharmaceutical composition of not less than 100 mg/ml, and a polyol in
|
